Stocks · Health care · Medicinal Chemicals & Botanical Products

Bon Natural Life Ltd

BON Clue Score43
China Fiscal year ends September CIK 0001816815
$1.13 -2.71% Close, 12 Oct 2026
Price $1.13 −47.26% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 27 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue16.4Operating income3.2Net income2.6EPS, diluted0.50Fiscal year 2020Revenue18.2 +11.1%Operating income3.5Net income3.0 +17.6%EPS, diluted0.58Fiscal year 2021Revenue25.5 +39.9%Operating income5.4Net income4.6 +51.7%EPS, diluted0.68Fiscal year 2022Revenue29.9 +17.3%Operating income6.6Net income6.2 +35.9%EPS, diluted7.43Fiscal year 2023Revenue29.5 −1.3%Operating income5.9Net income4.6 −26.3%EPS, diluted124.92Fiscal year 2024Revenue23.8 −19.2%Operating income1.9Net income0.4 −91.3%EPS, diluted4.14Fiscal year 2025Revenue18.7 −21.7%Operating income−1.6Net income−2.0 −601.0%EPS, diluted−0.72
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 16.4 18.2 25.5 29.9 29.5 23.8 18.7
Growth +11.1% +39.9% +17.3% −1.3% −19.2% −21.7%
Operating income 3.2 3.5 5.4 6.6 5.9 1.9 −1.6
Net income 2.6 3.0 4.6 6.2 4.6 0.4 −2.0
Growth +17.6% +51.7% +35.9% −26.3% −91.3% −601.0%
EPS, diluted 0.50 0.58 0.68 7.43 124.92 4.14 −0.72

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin32.2%Operating margin19.4%Net margin15.7%Free cash flow margin42.0%Fiscal year 2020Gross margin28.6%Operating margin19.0%Net margin16.6%Free cash flow margin14.3%Fiscal year 2021Gross margin27.9%Operating margin21.2%Net margin18.0%Free cash flow margin15.7%Fiscal year 2022Gross margin31.5%Operating margin22.1%Net margin20.9%Free cash flow margin−0.7%Fiscal year 2023Gross margin29.9%Operating margin20.1%Net margin15.6%Free cash flow margin−2.3%Fiscal year 2024Gross margin29.8%Operating margin7.9%Net margin1.7%Free cash flow margin−32.4%Fiscal year 2025Gross margin20.8%Operating margin−8.7%Net margin−10.7%Free cash flow margin0.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 32.2% 28.6% 27.9% 31.5% 29.9% 29.8% 20.8%
Operating margin 19.4% 19.0% 21.2% 22.1% 20.1% 7.9% −8.7%
Net margin 15.7% 16.6% 18.0% 20.9% 15.6% 1.7% −10.7%
Free cash flow margin 42.0% 14.3% 15.7% −0.7% −2.3% −32.4% 0.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow7.1Capital expenditure−0.2Free cash flow6.9Fiscal year 2020Operating cash flow2.6Capital expenditure−0.0Free cash flow2.6 −62.1%Fiscal year 2021Operating cash flow4.1Capital expenditure−0.1Free cash flow4.0 +53.2%Fiscal year 2022Operating cash flow−0.2Capital expenditure−0.0Free cash flow−0.2 −105.4%Fiscal year 2023Operating cash flow−0.6Capital expenditure−0.1Free cash flow−0.7Fiscal year 2024Operating cash flow−7.7Capital expenditure−0.0Free cash flow−7.7Fiscal year 2025Operating cash flow0.1Capital expenditure−0.0Free cash flow0.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 7.1 2.6 4.1 −0.2 −0.6 −7.7 0.1
Capital expenditure −0.2 −0.0 −0.1 −0.0 −0.1 −0.0 −0.0
Free cash flow 6.9 2.6 4.0 −0.2 −0.7 −7.7 0.1
Growth −62.1% +53.2% −105.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2019Shareholders’ equity7.3Fiscal year 2020Total debt5.0Shareholders’ equity10.5Debt to equity0.48Fiscal year 2021Cash and securities3.6Total debt2.7Net cash (debt)0.9Shareholders’ equity26.0Debt to equity0.10Fiscal year 2022Cash and securities0.8Total debt4.8Net cash (debt)−3.9Shareholders’ equity29.6Debt to equity0.16Fiscal year 2023Cash and securities0.1Total debt3.8Net cash (debt)−3.7Shareholders’ equity35.5Debt to equity0.11Fiscal year 2024Cash and securities0.1Total debt7.2Net cash (debt)−7.1Shareholders’ equity43.9Debt to equity0.16Fiscal year 2025Cash and securities6.3Total debt12.2Net cash (debt)−5.9Shareholders’ equity57.6Debt to equity0.21
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities n/a n/a 3.6 0.8 0.1 0.1 6.3
Total debt n/a 5.0 2.7 4.8 3.8 7.2 12.2
Net cash (debt) n/a n/a 0.9 −3.9 −3.7 −7.1 −5.9
Shareholders’ equity 7.3 10.5 26.0 29.6 35.5 43.9 57.6
Debt to equity n/a 0.48 0.10 0.16 0.11 0.16 0.21

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022† 30 Sep 2022 FY2023† 30 Sep 2023 FY2024† 30 Sep 2024 FY2025† 30 Sep 2025
Operations
7.1 2.6 4.1 −0.2 −0.6 −7.7 0.1
Growth −62.8% +53.3% −104.6%
0.2 0.2 0.2 0.2 1.0 n/a n/a
Investment
−0.2 −0.0 −0.1 −0.0 −0.1 −0.0 −0.0
calc 6.9 2.6 4.0 −0.2 −0.7 −7.7 0.1
Growth −62.1% +53.2% −105.4%
calc 1.33 0.50 0.60 −0.26 −18.45 −80.43 0.05
−8.4 −3.0 −7.4 −3.1 −1.2 −0.0 −10.0
Financing
0.8 0.1 5.4 2.3 1.2 8.8 15.5

† The diluted share count jumps at 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.